Regulus Therapeutics Inc. (RGLS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.48+0.06 (+1.78%)
As of 2:47 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.42
Bid3.47 x 1000
Ask3.48 x 100
Day's Range3.38 - 3.52
52wk Range2.44 - 10.60
1y Target EstN/A
Market Cap183.86M
P/E Ratio (ttm)-2.92
Avg Vol (3m)651,223
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Kiplinger4 hours ago

    3 Battered Biotechs That Could Turn Things Around

    The fallout in biotech stocks has created risky, but enticing, opportunities.

  • Capital Cube20 days ago

    ETF’s with exposure to Regulus Therapeutics, Inc. : September 7, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Regulus Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to RGLS-US. Comparing the performance and risk of Regulus Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire27 days ago

    Regulus to Present at the 2016 Wells Fargo Healthcare Conference

    LA JOLLA, Calif., Aug. 31, 2016 /PRNewswire/ --  Regulus Therapeutics Inc . (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, ...